abstract |
FIELD: biochemistry.SUBSTANCE: invention relates to an antibody which specifically binds to PD-1. Also disclosed is a composition comprising said antibody, a polynucleotide encoding said antibody, a vector and a host cell containing said polynucleotide. Disclosed are methods of treating cancer and infectious diseases associated with PD-1, reducing a tumor associated with PD-1, a method for increasing T-cell activation.EFFECT: invention provides effective treatment of diseases associated with PD-1.42 cl, 19 dwg, 8 ex, 16 tbl |